ANGIODYNAMICS INC - 8-K Filing

AngioDynamics reports Q4 and FY 2026 financial results with record Med Tech growth (Items: 2.02 of this Form 8-K (including Exhibit 99, 7.01 of this Form 8-K (including Exhibit 99)

SEC EDGAR ·

Tickers: $ANGO

Read the full article at SEC EDGAR

More Regulatory news